Results

Total Results: 2,327 records

Showing results for "response".

201. Treatment of Osteoarthritis of the Knee: An Update Review (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/osteoarthritis-knee-update-disposition.pdf
     May 04, 2017 - No further response needed. … No further response needed. … No further response needed. … No response needed. … No response needed.

202. Treatment of Osteoarthritis of the Knee: An Update Review (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/osteoarthritis-knee-update-disposition-archived.pdf
     May 04, 2017 - No further response needed. … No further response needed. … No further response needed. … No response needed. … No response needed.

203. Major-Depressive-Disorder Executive (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/major-depressive-disorder_executive.pdf
     December 01, 2015 - with depression that is harder to treat, as evidenced by more difficulty in achieving treatment response … Inclusion/exclusion criteria (continued) Criteria Inclusion Exclusion Outcomes • Benefits: response … to treatment, remission, speed of response, speed of remission, relapse, quality of life, functional … Our outcome measure of choice was the rate of response on the Hamilton Depression Rating Scale 6 … Adding CBT to SGA did not show any benefit in remission or response, as defined previously, and led

204. Research Review Title: Infection Prevention and Control for the Emergency Medical Services and 911 Workforce (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/ems-911-workforce-disposition-comments.pdf
     November 01, 2022 - workforce-infection-control/report Published Online: November 1, 2022 2 Summary of Peer Reviewer Comments and Author Response … workforce-infection-control/report Published Online: November 1, 2022 3 Public Comments and Author Response … Commentator & Affiliation Section Comment Response NASEMSO ES-1 Executive Summary ES-1 … workforce-infection-control/report Published Online: November 1, 2022 4 Commentator & Affiliation Section Comment Response … (response above) Aubrey Brown Executive Summary, Results, paragraph 4 One study demonstrated that

205. Disposition of Comments CER 219 Antipsychotics for the Prevention and Treatment of Delirium (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/delirium-disposition-comments.pdf
     September 03, 2019 - In response we have included the following points in the Discussion on page 146: “Symptom reporting … For example, as noted in our response to Comment #10, studies are heterogeneous enough in exposure … Nonetheless, some response to this, or commentary on what has been reported in other studies may be … It is unclear to me what low and medium mean, so perhaps a footnote describing response options and … In response to this reviewer we have added text to provide context regarding the consistency and strength

206. Layout 1 (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/antidepressants-update_executive.pdf
     December 01, 2011 - The evidence is insufficient to determine factors that can reliably predict response or nonresponse in … • Sertraline versus venlafaxine (3 studies; 470 patients): Pooled response rates were similar for … The strength of evidence is moderate. 6 Speed of Response Seven studies, all of fair quality and … Response to Antidepressant Agents After Successful Response in the Past (KQ 1b) We did not find any … Low One trial reported higher response rates for venlafaxine XR than venlafaxine IR.

207. Psoriatic Arthritis Surveillance Assesment_CER 54_Low (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/arthritis-psoriatric_surveillance.pdf
     March 01, 2013 - ACR50 response rates were 36%, 69%, and 87% respectively (p= .0001 and .03, respectively). … A new meta-analysis9 found PsA Response Criteria (PsARC) response at 12-14 weeks was significantly … ACR20 response at 12-16 weeks was greater for both anti-TNFs and other biologics. … Psoriasis area and severity index (PASI) response was greater the FDA in October, 2012. … ACR50 response rates were Did not conduct statistical tests on adverse events data.

208. Disposition of Comments Report for CER 132 Combination Therapy Versus Intensification of Statin Monotherapy: An Update (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/high-cholestorol-medicines-update_disposition-comments.pdf
     September 01, 2014 - displayproduct&productID=1860 Published Online: February 11, 2014 1 Commentator Section Comments Response … This whole document was prepared through the narrow lens of a methodological response to the wrong … I think that if you use studies whose duration is 12 months or less you should consider them dose response … Also, no mention is made of the genetic variations in response to statins and that perhaps one should … Further, we did not examine differences in statin response based on genetic variations PCSK-9 is

209. Data-Points-6-Maps (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/data-points-6-maps.pdf
     August 22, 2011 - Annual Utilization of Biologic Response Modifiers Among Continually Enrolled Medicare Parts A and B Fee-for-Service … Annual Utilization of Biologic Response Modifiers Among Continually Enrolled Medicare Parts A and B Fee-for-Service … Annual Utilization of Biologic Response Modifiers Among Continually Enrolled Medicare Parts A and B Fee-for-Service … Annual Utilization of Biologic Response Modifiers Among Continually Enrolled Medicare Parts A and B Fee-for-Service

210. Masks for Prevention of COVID-19 in Community and Healthcare Settings: A Living Rapid Review | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/products/masks-covid/rapid-review
     January 01, 2022 - COVID-19 Pandemic Rapid Evidence Product | Oct 5, 2020 Resource Allocation and Pandemic Response … Rooms in Acute Care Settings: A Rapid Review Rapid Evidence Product | Oct 28, 2022 Antibody Response … You Might Also Like Rapid Evidence Product Oct 28, 2022 Antibody Response … Rapid Review Rapid Evidence Product Oct 05, 2020 Resource Allocation and Pandemic Response

211. Anxiety in Children | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/products/anxiety-children/research-2017
     January 01, 2020 - symptoms based on child, parent, and clinician reports, improves functioning, and leads to clinical response … Tricyclic antidepressants marginally improved clinical response (low SOE). … improved primary anxiety symptoms (clinician, child, and parent report), function, remission, and clinical response … CBT reduced primary anxiety symptoms (clinician report), improved function, and increased clinical response

212. Disposition of Comments: Comparative Effectiveness Review No. 239: Acute Treatments for Episodic Migraine (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/cer-239-episodic-migraine-comments.pdf
     December 29, 2020 - www.effectivehealthcare.ahrq.gov/reports/final.cfm Summary of Public Reviewer Comments and Author Response … research Published Online: December 29, 2020 3 : Commentator & Affiliation Section Comment Response … migraine-treatments/research Published Online: December 29, 2020 4 Commentator & Affiliation Section Comment Response … migraine-treatments/research Published Online: December 29, 2020 5 Commentator & Affiliation Section Comment Response

213. Untitled (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/hepatitis-c_surveillance.pdf
     December 01, 2015 - Results indicated better sustained virologic response associated with the study drug. … Sustained virological response •! … Dual therapy with Pegylated Interferon Alfa-2a plus Ribavirin Outcome: Sustained viroligic response … Alfa-2b and Duration effects Outcome: Sustained viroligic response SOE: Low 1 trial of response-guided … Alfa-2b and Duration effects Outcome: Sustained viroligic response SOE: Low 1 trial of response-guided

214. Untitled (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/hepatitis-c_surveillance.pdf
     December 01, 2015 - Results indicated better sustained virologic response associated with the study drug. … Sustained virological response •! … Dual therapy with Pegylated Interferon Alfa-2a plus Ribavirin Outcome: Sustained viroligic response … Alfa-2b and Duration effects Outcome: Sustained viroligic response SOE: Low 1 trial of response-guided … Alfa-2b and Duration effects Outcome: Sustained viroligic response SOE: Low 1 trial of response-guided

215. Disposition of Comments Report for Outpatient Case Management for Adults With Medical Illness and Complex Care Needs (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/case-management_disposition-comments.pdf
     January 01, 2013 - www.effectivehealthcare.ahrq.gov Published Online: Month XX, 20XX 2 Commentator & Affiliation Section Comment Response … www.effectivehealthcare.ahrq.gov Published Online: Month XX, 20XX 3 Commentator & Affiliation Section Comment Response … www.effectivehealthcare.ahrq.gov Published Online: Month XX, 20XX 4 Commentator & Affiliation Section Comment Response … www.effectivehealthcare.ahrq.gov Published Online: Month XX, 20XX 5 Commentator & Affiliation Section Comment Response … www.effectivehealthcare.ahrq.gov Published Online: Month XX, 20XX 6 Commentator & Affiliation Section Comment Response

216. Effectiveness of Screening and Treatment of Subclinical Hypothyroidism or Hyperthyroidism (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/hypothyroidism-hyperthyroidism-screening-treatment_disposition-comments.pdf
     February 01, 2012 - (NOTE: See also response to comment #16, below). … Rodondi and ask him; awaiting a response. … Thank you – no response required Peer Reviewer #12 Results The results section is complete. … Thank you – no response required Peer Reviewer #12 Clarity and Usability It would be helpful … See response to comment #96.

217. CER 218 Disposition of Comments: Long-Term Drug Therapy and Drug Holidays for Osteoporosis Fracture Prevention (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/cer-218-osteoporosis-disposition-comments.pdf
     April 23, 2019 - osteoporosis-fracture-prevention/research Published Online: April 23, 2019 2 Section Commentator & Affiliation Comment Response … osteoporosis-fracture-prevention/research Published Online: April 23, 2019 3 Section Commentator & Affiliation Comment Response … osteoporosis-fracture-prevention/research Published Online: April 23, 2019 4 Section Commentator & Affiliation Comment Response … osteoporosis-fracture-prevention/research Published Online: April 23, 2019 5 Section Commentator & Affiliation Comment Response … osteoporosis-fracture-prevention/research Published Online: April 23, 2019 6 Section Commentator & Affiliation Comment Response

218. Strategies to De-escalate Aggressive Behavior in Psychiatric Patients (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/aggression_disposition-comments.pdf
     July 14, 2016 - productid=2256 Published Online: July 14, 2016 2 Section Commentator and Affiliation Comment Response … productid=2256 Published Online: July 14, 2016 3 Section Commentator and Affiliation Comment Response … productid=2256 Published Online: July 14, 2016 4 Section Commentator and Affiliation Comment Response … productid=2256 Published Online: July 14, 2016 5 Section Commentator and Affiliation Comment Response … Too many studies of agitation/aggression have focused solely on reduction of level of agitation response

219. Treatment for Restless Legs Syndrome Disposition of Comments Report (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/restless-legs_disposition-comments.pdf
     November 27, 2012 - Peer Reviewer #2 Results There clearly are trials that show a dose response for dopamine agonists … All of the numerous statements about lack of dose response need to be eliminated. … The authors somehow state response is not a dose response. … Public Comment Results Long-Term Harms/Withdrawal from Treatment – please see enclosed response … Reviewer #8 Kimberly Moran, PhD Medical Director, CNS UCB Placebo Response We agree with

220. Disposition of Comments for Venous Thromboembolism Prophylaxis in Orthopedic Surgery (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/blood-clots-hip-knee-surgery_disposition-comments.pdf
     March 01, 2012 - A) Please see the response above. … D) Please see the response above. … Please see response above. … A) Please see response above. … Please see response to KQ 6.